Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

MAB3315

Sigma-Aldrich

Anti-MMP-7 Antibody, clone 141-7B2

clone 141-7B2, Chemicon®, from mouse

Synonyme(s) :

Matrilysin

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352203
eCl@ss :
32160702
Nomenclature NACRES :
NA.41

Source biologique

mouse

Niveau de qualité

Forme d'anticorps

purified immunoglobulin

Clone

141-7B2, monoclonal

Espèces réactives

human

Fabricant/nom de marque

Chemicon®

Technique(s)

ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable

Isotype

IgG1κ

Numéro d'accès NCBI

Numéro d'accès UniProt

Conditions d'expédition

dry ice

Modification post-traductionnelle de la cible

unmodified

Spécificité

The antibody specifically reacts with precursor form of human MMP-7. Does not cross-react with the active forms of human MMP-7 and human MMP-1, 2, 3, 8, 9 and 13.

Immunogène

Rectal carcinoma (SW837) cells.

Application

Anti-MMP-7 Antibody, clone 141-7B2 is an antibody against MMP-7 for use in ELISA, WB, IH(P).
Immunoblotting: 10 μg/mL Molecular weight band around 30kDa.

Immunohistochemistry on paraffin-embedded tissue sections: 4-20 μg/mL

EIA

Optimal working dilutions must be determined by end user.
Research Category
Cell Structure
Research Sub Category
MMPs & TIMPs

Forme physique

Format: Purified
Purified immunoglobulin. Liquid in 0.1 M sodium phosphate buffer, pH 7.0 containing 2% protease-free bovine serum albumin.

Stockage et stabilité

Maintain at -20°C in undiluted aliquots for up to 12 months from date of receipt. Avoid repeated freeze/thaw cycles.

Autres remarques

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Informations légales

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Manufactured by Daiichi Fine Chemical Co., Ltd

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Code de la classe de stockage

12 - Non Combustible Liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Yali Zhai et al.
The American journal of pathology, 160(4), 1229-1238 (2002-04-12)
In various cancers, inactivating mutations in the adenomatous polyposis coli or Axin tumor suppressor proteins or activating mutations in beta-catenin's amino-terminal domain elevate beta-catenin levels, resulting in marked effects on T-cell factor (TCF)-regulated transcription. Several candidate beta-catenin/TCF-regulated genes in cancer
Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis.
Makitalo, L; Piekkala, M; Ashorn, M; Pakarinen, M; Koivusalo, A; Karikoski, R; Natunen et al.
World Journal of Gastroenterology null
DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
Chen, YJ; Lee, LY; Chao, YK; Chang, JT; Lu, YC; Li, HF; Chiu, CC; Li, YC; Li, YL; Chiou et al.
Testing null
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara, F, et al.
Journal of Neuropathology and Experimental Neurology, 57, 839-849 (1998)
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
Fernanda Roca, Laura V Mauro, Ana Morandi, Fernando Bonadeo, Carlos Vaccaro et al.
Journal of Surgical Oncology null

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique